Flynn Zito Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Flynn Zito Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-403	Closed	-$234K	–	164
2025 Q4	$234K	Buy	+403	New	+$228K	0.08%	122
2025 Q2	–	Sell	-408	Closed	-$203K	–	131
2025 Q1	$203K	Buy	408 +5	+1%	+$2.71K	0.09%	120
2024 Q4	$210K	Hold	403	–	–	0.1%	117
2024 Q3	$249K	Buy	403 +7	+2%	+$4.14K	0.12%	96
2024 Q2	$219K	Hold	396	–	–	0.11%	105
2024 Q1	$230K	Sell	396 -121	-23%	-$67.9K	0.12%	98
2023 Q4	$274K	Hold	517	–	–	0.19%	65
2023 Q3	$262K	Hold	517	–	–	0.18%	54
2023 Q2	$270K	Hold	517	–	–	0.18%	57
2023 Q1	$298K	Sell	517 -265	-34%	-$149K	0.22%	53
2022 Q4	$431K	Sell	782 -335	-30%	-$178K	0.36%	44
2022 Q3	$567K	Buy	+1,117	New	+$625K	0.56%	29
2022 Q2	–	Sell	-1,118	Closed	-$660K	–	119
2022 Q1	$660K	Sell	1,118 -4	-0.4%	-$2.3K	0.56%	31
2021 Q4	$749K	Buy	+1,122	New	+$701K	0.63%	28

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Flynn Zito Capital Management's TMO Position: Q1 2026 in Review

Flynn Zito Capital Management sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 403 shares — an estimated $234K sold.

Flynn Zito Capital Management first reported a position in TMO in Q4 2021 and held it in 14 quarters. The position peaked at $749K in Q4 2021. 2,612 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Flynn Zito Capital Management reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
Flynn Zito Capital Management sold 403 Thermo Fisher Scientific shares in Q1 2026, an estimated $234K.
Flynn Zito Capital Management first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 14 quarters.
Flynn Zito Capital Management's Thermo Fisher Scientific position peaked at $749K in Q4 2021.
2,612 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Flynn Zito Capital Management's 13F filing for Q1 2026, filed 4 May 2026.